Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of atomoxetine administered
once daily in the treatment of children and adolescents with ADHD and comorbid dyslexia.